HOME >> MEDICINE >> NEWS
International breast cancer prevention study launches in the United States and Canada

es national and international trials of cancer therapy, including trials for new cancer drugs, cancer prevention and supportive care to improve quality of life for people with cancer. Since its inception, the NCIC CTG has enrolled more than 40,000 patients from Canada and around the world in over 300 clinical trials.

Pfizer, Inc. manufactures exemestane under the brand name Aromasin and is providing the drug for the trial.

Women looking for more information about the ExCel research study and participating study centers in their community can visit www.excelstudy.com or call toll-free:

  • In the U.S. 1-800-4-CANCER
  • In Canada 1 888 939-3333

    About Exemestane

    Exemestane (Aromasin) was approved in the United States late in 1999 for the treatment of advanced breast cancer in postmenopausal women whose tumors have stopped responding to tamoxifen. Exemestane is approved by the FDA and Health Canada and is marketed by Pfizer, Inc. as Aromasin. It is also approved for use in Europe, Japan, and South America. It is currently used for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.

    Results of the Intergroup Exemestane Study, published in the New England Journal of Medicine, revealed that 32 percent fewer women had a recurrence in their breast cancer when they switched to exemestane after two to three years of tamoxifen compared to those who continued on tamoxifen for a total of five years, the current standard of care. Additionally, twice as many women receiving tamoxifen developed second (or new) breast cancers than those treated with exemestane.

    Unlike other aromatase inhibitors, exemestane is a steroidal aromatase inactivator, which means it selectively targets and irreversibly binds to the aromatase enzyme, which is required to produce estrogen. Without estrogen, breast can
    '"/>



  • Contact: Samantha Kaplan
    samantha.kaplan@edelman.com
    312-297-7439
    Edelman Public Relations
    30-Mar-2005


    Page: 1 2 3 4

    Related medicine news :

    1. National Academies advisory: May 2 Symposium on International Science Policy
    2. Awards & fellowships at the International & American Association for Dental Research General Session
    3. Lectures, keynoters, symposia highlight International Dental Research meeting
    4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
    5. International gathering of experts to share retinoblastoma breakthroughs
    6. International trial of two microbicides begins
    7. International gathering at UH examines top computer code
    8. International trial finds benefits of breast MRI in women at high risk
    9. International study provides culture-by-culture clues to family violence and abuse
    10. St. Jude scientist wins International Society of Experimental Hematology award
    11. International MRC trial finds a routine treatment for head injury may do more harm than good

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
    (Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
    (Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
    (Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
    Breaking Medicine News(10 mins):
    (Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
    (Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
    (Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
    Breaking Medicine Technology:
    Cached News: